C07K 14/8121
Serpins
Official title: {Serpins}
C07K14/8121 (Serpins) appears on 518 US grants and 593 published applications in this corpus.
Search patents in C07K- Granted patents
- 518
- Published applications
- 593
- Assignees
- 396
- Inventors
- 1,294
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 4 | 0 |
| 1985 | 3 | 0 |
| 1986 | 3 | 0 |
| 1987 | 4 | 0 |
| 1988 | 5 | 0 |
| 1989 | 6 | 0 |
| 1990 | 6 | 0 |
| 1991 | 7 | 0 |
| 1992 | 13 | 0 |
| 1993 | 11 | 0 |
| 1994 | 10 | 0 |
| 1995 | 14 | 0 |
| 1996 | 15 | 0 |
| 1997 | 21 | 0 |
| 1998 | 17 | 0 |
| 1999 | 18 | 0 |
| 2000 | 17 | 0 |
| 2001 | 15 | 5 |
| 2002 | 14 | 22 |
| 2003 | 10 | 28 |
| 2004 | 8 | 25 |
| 2005 | 8 | 19 |
| 2006 | 18 | 18 |
| 2007 | 14 | 16 |
| 2008 | 4 | 16 |
| 2009 | 6 | 12 |
| 2010 | 9 | 22 |
| 2011 | 7 | 17 |
| 2012 | 9 | 13 |
| 2013 | 8 | 18 |
| 2014 | 15 | 34 |
| 2015 | 15 | 26 |
| 2016 | 22 | 21 |
| 2017 | 19 | 35 |
| 2018 | 16 | 22 |
| 2019 | 24 | 19 |
| 2020 | 22 | 34 |
| 2021 | 14 | 33 |
| 2022 | 15 | 35 |
| 2023 | 11 | 34 |
| 2024 | 15 | 26 |
| 2025 | 15 | 25 |
| 2026 | 4 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Vectors encoding a glucose-6-phosphatase (G6PASE-A) for gene therapy1 Sep 2026US 12,723,263 B2Genethon
- RAAV-based compositions and methods19 May 2026US 12,630,824 B2University of Massachusetts
- Compositions and methods for treating alpha-1 antitrypsin deficiency12 May 2026US 12,622,931 B2Beam Therapeutics Inc.
- Paramyxovirus virus-like particles as protein delivery vehicles14 Apr 2026US 12,600,956 B2The Penn State Research Foundation
- Compositions and methods for linear and conformational site-specific antibodies and methods of making the same30 Dec 2025US 12,509,508 B2Abbratech, Inc.
- Serine proteinase inhibitors: serp-1 and serp-1 rcl-derived peptides effect on microbiome composition and uses thereof27 Aug 2026US 2026/0248876 A1Arizona Board of Regents on behalf of Arizona State University
- Gene-edited natural killer cells27 Aug 2026US 2026/0250634 A1Crispr Therapeutics AG
- Compositions and methods for prevention and treatment of genetic disease20 Aug 2026US 2026/0240889 A1Children's Medical Center Corporation
- Antivirus proteins having a kringle 5 subunit20 Aug 2026US 2026/0242447 A1Creative BioTherapeutics
- Protein complex and production process thereof6 Aug 2026US 2026/0226418 A1Darwin Biotechnology (Hubei) Co., Ltd.
Most cited
By later US patents
- Cysteine-pegylated proteins217US 5,766,897 AIncyte Pharmaceuticals, Inc. · 1998
- Pericardial delivery of therapeutic and diagnostic agents189US 5,797,870 AIndiana University Foundation · 1998
- Blood coagulation factors and process for their manufacture135US 4,297,344 ABehringwerke Aktiengesellschaft · 1981
- Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same124US 6,759,237 B1The Trustees of the University of Pennsylvania · 2004
- Eukaryotic regulatable transcription111US 4,876,197 AChiron Corporation · 1989